Effective gene therapy with nonintegrating lentiviral vectors. - Test2 - elhamkhani - TriplyDB

Effective gene therapy with nonintegrating lentiviral vectors.

Effective gene therapy with nonintegrating lentiviral vectors.

http://www.wikidata.org/entity/Q34496367

about

Lentiviral gene transfer of RPE65 rescues survival and function of cones in a mouse model of Leber congenital amaurosis Reconstitution of an infectious human endogenous retrovirus Correction of the disease phenotype in the mouse model of Stargardt disease by lentiviral gene therapy Lentiviral vectors in gene therapy: their current status and future potential Genetic manipulation for inherited neurodegenerative diseases: myth or reality?State-of-the-art human gene therapy: part I. Gene delivery technologies Gene therapy on the move Hematopoietic-stem-cell-based gene therapy for HIV disease Lentiviral expression of retinal guanylate cyclase-1 (RetGC1) restores vision in an avian model of childhood blindness Cortical overexpression of neuronal calcium sensor-1 induces functional plasticity in spinal cord following unilateral pyramidal tract injury in rat Protective Antiviral Immunity Conferred by a Nonintegrative Lentiviral Vector-Based Vaccine Gene therapy for hemophilia Biology and therapy of inherited retinal degenerative disease: insights from mouse models Identification of key residues determining isomerohydrolase activity of human RPE65 GABAergic circuits mediate the reinforcement-related signals of striatal cholinergic interneurons Potential therapeutic approaches for modulating expression and accumulation of defective lamin A in laminopathies and age-related diseases Non-integrative lentivirus drives high-frequency cre-mediated cassette exchange in human cells Driving DNA transposition by lentiviral protein transduction Retinal degeneration progression changes lentiviral vector cell targeting in the retina Human immunodeficiency virus type 1 Vpu and cellular TASK proteins suppress transcription of unintegrated HIV-1 DNA.Gene therapy regenerates protein expression in cone photoreceptors in Rpe65(R91W/R91W) mice.Immunologic and Virologic Mechanisms for Partial Protection from Intravenous Challenge by an Integration-Defective SIV Vaccine.Molecular engineering of viral gene delivery vehicles Genomic insertion of lentiviral DNA circles directed by the yeast Flp recombinase.Nonintegrating lentiviral vectors can effectively deliver ovalbumin antigen for induction of antitumor immunity.Lentiviral-vector-mediated expression of murine IL-1 receptor antagonist or IL-10 reduces the severity of endotoxin-induced uveitis Long-term episomal transgene expression from mitotically stable integration-deficient lentiviral vectors.Integrase-Deficient Lentiviral Vector as an All-in-One Platform for Highly Efficient CRISPR/Cas9-Mediated Gene Editing Lentiviral vectors can be used for full-length dystrophin gene therapy Sleeping beauty transposition from nonintegrating lentivirus.Hybrid lentivirus-transposon vectors with a random integration profile in human cells.Mechanism of reduction in titers from lentivirus vectors carrying large inserts in the 3'LTR.Puromycin-resistant lentiviral control shRNA vector, pLKO.1 induces unexpected cellular differentiation of P19 embryonic stem cells.Hybrid lentivirus-phiC31-int-NLS vector allows site-specific recombination in murine and human cells but induces DNA damage.Protein transduction from retroviral Gag precursors Gene therapy for monogenic liver diseases: clinical successes, current challenges and future prospects.Stable transgene expression in primitive human CD34+ hematopoietic stem/progenitor cells, using the Sleeping Beauty transposon system Transgenic expression of human glial cell line-derived neurotrophic factor from integration-deficient lentiviral vectors is neuroprotective in a rodent model of Parkinson's disease.Leber congenital amaurosis due to RPE65 mutations and its treatment with gene therapy Optimization of mucosal responses after intramuscular immunization with integrase defective lentiviral vector

P2860

Q21144697-4D0196FD-5191-4D9B-BF30-3A231431FB5C Q21559512-FF1A9D25-51E5-411D-B865-A9A533826E75 Q24621941-26E00B88-4AD8-4E27-A2FF-5AB73D6EE866 Q24629462-91A122A4-5714-4691-86D8-5FE099477C30 Q26752831-4EAE14A3-E20C-4413-8BFA-3582E0C6238D Q26825575-F996B867-1CBD-41A7-BFD9-C93A286662CC Q27007012-8E5A8240-EF8A-4B51-A3B6-AAAA924CC8B9 Q27023434-73582F5C-9D3C-44F0-A87D-398EAD44EBE2 Q27307727-341009E5-9AC3-40BC-BF73-A42AF674A711 Q27324189-A4BB9A13-77FE-4EF7-BC9B-603EBD1EE3A6 Q27487498-0D4262EE-AA37-4B20-A550-61F76DC2032A Q28081911-1AB544F6-FB58-40E7-9816-8E54171D8C11 Q28084726-B4D7902F-C2FF-46D2-A64B-34E5F833C014 Q28245764-2AE0E4B7-6F59-49A7-ACEB-4B0E76D1A5B5 Q28255137-42681DE4-00ED-46AF-AAD1-B86994B6FE31 Q28391383-73C90D6D-0B1E-4839-9B7C-D3B8A5D3EB63 Q28478217-968390D1-0ACD-42BF-A433-37BD40AA55DE Q28655839-F9609DB6-A318-41AC-80CA-B35DB681647B Q28741007-C1D8899A-275E-47E5-9DFB-44A147322930 Q30422793-7CB98148-DC43-4AB1-BBFB-1C859DD04D04 Q30999247-5CF9B979-4953-4C4F-AA30-239F2D41C6C2 Q32183405-72112502-DE82-442F-927F-26D0DB18FF35 Q33353795-653E9404-ED3C-4DB7-9E2F-CDB30A3810C4 Q33358990-8B1157CA-7DE5-470A-8BC7-BAB8084A2AC2 Q33564383-EDCE8963-B89F-44D7-8D4F-7E12B21361FB Q33629946-46F856A5-F1D0-4BB7-B1F9-6A5007BB83E5 Q33637259-F7821A7D-E014-4B7F-A4CF-B5F37D19C722 Q33655722-2010060D-712C-47A0-BFC3-6409DA7891F0 Q33668822-481AF9D4-A395-4FF4-98E8-1DF06AED07FB Q33713788-4AAD2965-FBA5-4A37-A885-FCDF9C07C6B3 Q33713812-174BD6BD-B868-434D-BAC4-467391E17BF7 Q33713951-89C5AC33-289E-4942-A86E-918F95A55C74 Q33772540-E1E9FB15-5F38-4024-8BFC-1A7441A318C9 Q33794201-6EE0ACA7-885C-4A67-8BED-6EAF94E04D32 Q33842785-55B407B3-EEBB-4F84-9EF9-DDE2C5F47CED Q33881920-FF56FE4B-420C-4D50-AA31-C2682C6DA1CC Q33888773-BB932554-6FF6-455D-A530-30FA595C7226 Q33903286-77C4F0DC-08CF-4E5A-B1FE-6E9AD8FA78EB Q33992484-A483DDC7-FF66-4DDC-9D9F-0A4895CA35A0 Q34166320-0B7E237C-43BC-490A-8720-AA4FED82A2D9

P2860

Effective gene therapy with nonintegrating lentiviral vectors.

http://www.wikidata.org/entity/Q34496367

description

2006 nî lūn-bûn

@nan

2006 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

name

Effective gene therapy with nonintegrating lentiviral vectors.

@ast

Effective gene therapy with nonintegrating lentiviral vectors.

@en

Effective gene therapy with nonintegrating lentiviral vectors.

@nl

type

label

Effective gene therapy with nonintegrating lentiviral vectors.

@ast

Effective gene therapy with nonintegrating lentiviral vectors.

@en

Effective gene therapy with nonintegrating lentiviral vectors.

@nl

prefLabel

Effective gene therapy with nonintegrating lentiviral vectors.

@ast

Effective gene therapy with nonintegrating lentiviral vectors.

@en

Effective gene therapy with nonintegrating lentiviral vectors.

@nl

P1433

Q34496367-D90CF731-FBA0-43A9-9B6D-2EE192976AA5

P1476

Q34496367-4B378271-58EC-44CD-BEC3-B198C040BF44

P2093

Q34496367-15801F3F-C24F-4A93-B356-A2A86685F9BA

Q34496367-2123F128-C719-4CBB-82DA-3A557F599671

Q34496367-3401E4A5-7393-4EE5-ACE2-808C1582C9FE

Q34496367-36CA5269-67C0-4BCC-9811-3BEE2A83C2C7

Q34496367-370E4DA6-564D-4E28-B1FB-5F8DF74CDF74

Q34496367-76C08DD3-1950-49B0-A856-55305F759751

Q34496367-7E0917B2-56BB-4C9D-AA28-4A9EA75AE0B0

Q34496367-851733C5-BB8D-46FF-B5C7-4C9CC5B5CE04

Q34496367-9E73C544-871C-413A-A7E8-D27C3FEF5BA9

Q34496367-C1921622-0000-4F40-805F-39480687C0D0

P2860

Q34496367-0B5DB606-8889-4908-8BCD-2276D9B72EBF

Q34496367-0B6302AE-B86C-423C-9FBC-CDB8B4A4DB7B

Q34496367-0D295521-0FBF-4D08-A159-81A299D66C3D

Q34496367-30902FF0-476E-4B13-90A3-1BB65B348B2D

Q34496367-3447DD23-16F9-44FC-8AB2-689CD4C3D4B8

Q34496367-39B7F690-6FE3-4C7E-9453-54921CBAB999

Q34496367-3A0108FF-34D6-4E27-ABE6-670173FC21B0

Q34496367-3FC4B454-5B5C-42CF-A3E6-76C0203D9373

Q34496367-46449410-6E8C-4D48-A7A1-7E9F34A7DEF7

Q34496367-4D039C12-C133-44B7-B3AA-8D66160B265F

P2888

Q34496367-2CE374A2-D101-451F-80BE-CC6DD6ED20DA

P304

Q34496367-F116FC58-7D95-4933-AB2F-6BD58B5F8992

P31

Q34496367-2176A782-18AF-4A91-9D49-33B121FB249E

P356

Q34496367-C9D0FF4C-83D1-4E1C-BC4A-DC912859D5A6

P407

Q34496367-F68E1A6E-C44B-470D-9055-04240A151979

P433

Q34496367-175F0193-1447-4035-94F2-BFE04A196BB8

P478

Q34496367-1FC5C23E-5748-48A1-949B-40F21DF5E9AD

P50

Q34496367-39ED432F-7E5A-452E-AE08-CE5C8255E19C

Q34496367-7D68B1ED-65A0-4D32-B50A-965AD60096A1

Q34496367-CF2EFA07-6907-48CB-974C-DD2A8133D744

P577

Q34496367-9D13C427-FDC4-460F-8E3D-AF7CB10DFF68

P5875

Q34496367-07012A21-6F7B-416D-AD49-D28AD4050EBF

P698

Q34496367-71E9DB1E-E9D1-40AC-8BAB-687DC0555C1C

P921

Q34496367-02243E09-04CA-4DB2-BDFD-9E6364523299

P356

P1433

Nature Medicine

P1476

Effective gene therapy with nonintegrating lentiviral vectors.

@en

P2093

Alexander J Smith

http://www.w3.org/2001/XMLSchema#string

Angus MacNeil

http://www.w3.org/2001/XMLSchema#string

Christine Kinnon

http://www.w3.org/2001/XMLSchema#string

Cynthia Bartholomae

http://www.w3.org/2001/XMLSchema#string

John R Heckenlively

http://www.w3.org/2001/XMLSchema#string

Kamaljit S Balaggan

http://www.w3.org/2001/XMLSchema#string

Manfred Schmidt

http://www.w3.org/2001/XMLSchema#string

Patrick N Anderson

http://www.w3.org/2001/XMLSchema#string

Prateek Buch

http://www.w3.org/2001/XMLSchema#string

Rafael J Yáñez-Muñoz

http://www.w3.org/2001/XMLSchema#string

P2860

LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1

In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector

Side effects of retroviral gene transfer into hematopoietic stem cells.

Stable transduction of quiescent CD34(+)CD38(-) human hematopoietic cells by HIV-1-based lentiviral vectors

Simian virus 40-based replication of catalytically inactive human immunodeficiency virus type 1 integrase mutants in nonpermissive T cells and monocyte-derived macrophages

Efficient transfer, integration, and sustained long-term expression of the transgene in adult rat brains injected with a lentiviral vector.

Intrinsic stability of episomal circles formed during human immunodeficiency virus type 1 replication.

Human immunodeficiency virus cDNA metabolism: notable stability of two-long terminal repeat circles.

Mapping unintegrated avian sarcoma virus DNA: termini of linear DNA bear 300 nucleotides present once or twice in two species of circular DNA.

Stability of lentiviral vector-mediated transgene expression in the brain in the presence of systemic antivector immune responses.

P2888

P304

348-353

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/NM1365

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

12

http://www.w3.org/2001/XMLSchema#string

P50

Christof von Kalle

Robert E. MacLaren

Adrian J Thrasher

P577

2006-02-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

32890557

http://www.w3.org/2001/XMLSchema#string

P698

16491086

http://www.w3.org/2001/XMLSchema#string

P921